Stockreport

SAB Biotherapeutics announces public stock offering; shares down [Seeking Alpha]

SAB Biotherapeutics, Inc.  (SABS) 
PDF The offering includes an option for underwriters to buy up to 15% additional securities within 30 days. All securities in the offering will be sold directly by the co [Read more]